Diversified Trust Co. Has $10.68 Million Position in Medtronic PLC $MDT

Diversified Trust Co. boosted its position in Medtronic PLC (NYSE:MDT) by 14.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 111,179 shares of the medical technology company’s stock after purchasing an additional 14,304 shares during the quarter. Diversified Trust Co.’s holdings in Medtronic were worth $10,680,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MDT. Corundum Trust Company INC acquired a new stake in shares of Medtronic during the third quarter worth $27,000. Board of the Pension Protection Fund acquired a new position in shares of Medtronic in the fourth quarter valued at about $29,000. GoalVest Advisory LLC acquired a new position in shares of Medtronic in the fourth quarter valued at about $29,000. Valley Wealth Managers Inc. bought a new position in Medtronic during the third quarter worth about $29,000. Finally, Delos Wealth Advisors LLC bought a new position in Medtronic during the second quarter worth about $27,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on MDT. CICC Research started coverage on shares of Medtronic in a report on Friday, January 30th. They issued an “outperform” rating for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $120.00 target price on shares of Medtronic in a report on Tuesday, March 10th. Truist Financial dropped their price target on shares of Medtronic from $107.00 to $103.00 and set a “hold” rating for the company in a research report on Wednesday, February 18th. Leerink Partners reiterated an “outperform” rating and issued a $119.00 price target on shares of Medtronic in a research note on Tuesday, March 10th. Finally, Mizuho raised Medtronic to a “strong-buy” rating in a research report on Wednesday, February 18th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $110.74.

Insider Buying and Selling at Medtronic

In related news, EVP Harry Skip Kiil sold 52,524 shares of Medtronic stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $97.71, for a total transaction of $5,132,120.04. Following the sale, the executive vice president directly owned 32,768 shares of the company’s stock, valued at approximately $3,201,761.28. The trade was a 61.58% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.26% of the company’s stock.

Medtronic Stock Up 1.3%

Shares of MDT opened at $87.24 on Tuesday. The firm has a 50 day simple moving average of $96.63 and a two-hundred day simple moving average of $96.69. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.54 and a quick ratio of 1.87. Medtronic PLC has a one year low of $79.55 and a one year high of $106.33. The company has a market cap of $112.01 billion, a P/E ratio of 24.30, a P/E/G ratio of 2.21 and a beta of 0.71.

Medtronic (NYSE:MDT) last issued its quarterly earnings results on Tuesday, February 17th. The medical technology company reported $1.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.02. Medtronic had a return on equity of 14.82% and a net margin of 13.00%.The company had revenue of $9.02 billion for the quarter, compared to analyst estimates of $8.89 billion. During the same quarter last year, the company posted $1.38 EPS. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Research analysts forecast that Medtronic PLC will post 5.46 EPS for the current fiscal year.

Medtronic Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 17th. Stockholders of record on Friday, March 27th will be issued a $0.71 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 3.3%. Medtronic’s dividend payout ratio is 79.11%.

About Medtronic

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).